公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA取消

317 记录

产品持有公司班级有效性
Dengue virus (IgG)10338930125EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Anti-Citomegalovírus IgM10338930126EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus em LCR (IgG)10338930128EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Bordetella pertussis (IgM)10338930129EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Anti-Citomegalovírus IgG10338930130EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-HSV-1/2 IgG em Líquor10338930119EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII15/09/2034
Anti-Citomegalovírus IgG avidez10338930117EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV01/09/2034
Chlamydia pneumoniae (IgG)10338930105EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Rubéola IgG em Líquor10338930106EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Rubéola IgG10338930107EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Chlamydia pneumoniae (IgA)10338930108EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Rubéola Avidez IgG10338930109EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Chlamydia trachomatis (IgG)10338930110EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Toxoplasma gondii em LCR (IgG)10338930111EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Rubéola IgM10338930112EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Toxoplasma gondii avidez (IgG)10338930113EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Toxoplasma gondii (IgM)10338930114EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Anti-Chlamydia trachomatis (IgA)10338930115EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
EUROLINE Paraneoplastic Neurologic Syndromes 12 Ag (IgG)10338930322EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/08/2034
IF: Treponema pallidum IgG10338930101EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/07/2034
Toxoplasma gondii (IgG)10338930103EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/07/2034
Chlamydia pneumoniae (IgM)10338930104EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/07/2034
IF: Treponema Pallidum IgM10338930100EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV21/07/2034
ANTI-HSV 1/2 IGG10338930097EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII10/06/2034
ANTI-CLAMIDIA MIF IGM10338930093EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV19/05/2034

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家